Breast cancer classification and prognosis based on gene expression profiles from a population-based study

Area of Science:

• Genomics
• Oncology
• Molecular Biology

Background:

• Gene expression profiling offers insights into breast cancer heterogeneity.
• Understanding molecular subtypes is crucial for predicting patient outcomes.

Purpose of the Study:

• To correlate comprehensive gene expression patterns with clinico-pathological features and survival in breast cancer patients.
• To identify novel gene expression markers associated with relapse-free survival.

Main Methods:

• cDNA microarray analysis of 99 breast cancer patients.
• Hierarchical cluster analysis to group tumors based on gene expression and ER status.
• Cox proportional hazards regression to identify survival-associated genes.

Main Results:

• Gene expression strongly associated with estrogen receptor (ER) status, moderately with grade.
• ER status-based clustering revealed basal and luminal subtypes.
• 16 genes significantly associated with relapse-free survival (P < 0.001).
• 14 of 93 previously reported survival-associated probe elements showed univariate association (P < 0.05).
• Genes involved in cell cycle, DNA replication, and chromosomal stability were elevated in poor prognostic groups.
• Glutathione S-transferase M3 identified as a significant survival marker.

Conclusions:

• Gene expression profiles provide valuable biological and clinical information in breast cancer.
• ER status is a key determinant of gene expression patterns and tumor subtypes.
• Specific gene signatures can predict relapse-free survival in breast cancer patients.